To test this prediction, we first cultured negatively selected CD3+ T cells from healthy controls with purified CLL cells at a 1:10 ratio for 48 h, in the presence or absence of 250 ng/ml of CXCL12. Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.